Erik Ostrowski

Insider Reports History

Location
Cambridge, MA
Signature
/s/Carolyn Rucci, attorney-in-fact for Erik Ostrowski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erik Ostrowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, CFO, CBO & Treasurer Common Stock 503,586 $1,848,160 $3.67 30 Jun 2025 Direct
AVROBIO, Inc. Interim CEO, President and CFO Restricted Stock Unit 120,249 $144,539 $1.20 01 Feb 2024 Direct
AVROBIO, Inc. Interim CEO, President and CFO Common Stock 29,285 $35,201 $1.20 05 Feb 2024 Direct
Akebia Therapeutics, Inc. SVP, CFO, CBO & Treasurer Stock Option (Right to buy) 292,300 31 Jan 2025 Direct

Insider Reports Filed by Erik Ostrowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 30 Jun 2025 1 -$151,622 4 SVP, CFO, CBO & Treasurer 01 Jul 2025, 17:01
AKBA Akebia Therapeutics, Inc. 31 Jan 2025 2 $0 4 SVP, CFO, CBO & Treasurer 04 Feb 2025, 17:48
AKBA Akebia Therapeutics, Inc. 28 Jun 2024 2 $0 4 SVP, CFO, CBO & Treasurer 02 Jul 2024, 16:31
AKBA Akebia Therapeutics, Inc. 24 Jun 2024 0 $0 3 SVP, CFO, CBO & Treasurer 26 Jun 2024, 17:37
AVRO AVROBIO, Inc. 01 Feb 2024 3 -$15,745 4 Interim CEO, President and CFO 05 Feb 2024, 19:57
AVRO AVROBIO, Inc. 01 Jul 2023 1 $0 4 Interim CEO, President and CFO 03 Jul 2023, 13:17
AVRO AVROBIO, Inc. 08 Feb 2023 1 $0 4 Chief Financial Officer 10 Feb 2023, 16:11
AVRO AVROBIO, Inc. 08 Dec 2022 1 $0 4 Chief Financial Officer 09 Dec 2022, 16:29
AVRO AVROBIO, Inc. 02 Feb 2022 2 $0 4 Chief Financial Officer 04 Feb 2022, 16:18
AVRO AVROBIO, Inc. 10 Jun 2021 1 $0 4 Chief Financial Officer 14 Jun 2021, 17:59